Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

[Age group, geographical incidence and patterns of antifungal susceptibility of Candida species causing candidemia in the Spanish paediatric population].

García-Rodríguez J, Cantón E, Pemán J, Alvarez M, Ezpeleta G, Gómez-Nieto A, Iglesias I, Martín-Mazuelos E, Ramírez-de Ocariz I, Rezusta A, Royo-García G; Grupo de Estudio FUNGEMYCA.

Enferm Infecc Microbiol Clin. 2013 Jun-Jul;31(6):363-8. doi: 10.1016/j.eimc.2012.09.018. Epub 2013 Feb 8. Spanish.

PMID:
23398860
2.

Candida orthopsilosis fungemias in a Spanish tertiary care hospital: incidence, epidemiology and antifungal susceptibility.

Blanco-Blanco MT, Gómez-García AC, Hurtado C, Galán-Ladero MA, Lozano Mdel C, García-Tapias A, Blanco MT.

Rev Iberoam Micol. 2014 Apr-Jun;31(2):145-8. doi: 10.1016/j.riam.2013.04.001. Epub 2013 May 13.

PMID:
23680638
3.

Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia.

Cantón E, Pemán J, Quindós G, Eraso E, Miranda-Zapico I, Álvarez M, Merino P, Campos-Herrero I, Marco F, de la Pedrosa EG, Yagüe G, Guna R, Rubio C, Miranda C, Pazos C, Velasco D; FUNGEMYCA Study Group.

Antimicrob Agents Chemother. 2011 Dec;55(12):5590-6. doi: 10.1128/AAC.00466-11. Epub 2011 Sep 19.

4.

Fungemia in a Spanish hospital: the role of Candida parapsilosis over a 15-year period.

Martí-Carrizosa M, Sánchez-Reus F, March F, Coll P.

Scand J Infect Dis. 2014 Jun;46(6):454-61. doi: 10.3109/00365548.2014.900190. Epub 2014 Apr 24.

PMID:
24762093
5.

Epidemiology of candidemia in Qatar, the Middle East: performance of MALDI-TOF MS for the identification of Candida species, species distribution, outcome, and susceptibility pattern.

Taj-Aldeen SJ, Kolecka A, Boesten R, Alolaqi A, Almaslamani M, Chandra P, Meis JF, Boekhout T.

Infection. 2014 Apr;42(2):393-404. doi: 10.1007/s15010-013-0570-4. Epub 2013 Dec 19.

PMID:
24352810
6.

Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital.

Miranda-Zapico I, Eraso E, Hernández-Almaraz JL, López-Soria LM, Carrillo-Muñoz AJ, Hernández-Molina JM, Quindós G.

J Antimicrob Chemother. 2011 Oct;66(10):2315-22. doi: 10.1093/jac/dkr298. Epub 2011 Jul 26.

PMID:
21795259
7.

Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.

Pemán J, Cantón E, Quindós G, Eraso E, Alcoba J, Guinea J, Merino P, Ruiz-Pérez-de-Pipaon MT, Pérez-del-Molino L, Linares-Sicilia MJ, Marco F, García J, Roselló EM, Gómez-G-de-la-Pedrosa E, Borrell N, Porras A, Yagüe G; FUNGEMYCA Study Group.

J Antimicrob Chemother. 2012 May;67(5):1181-7. doi: 10.1093/jac/dks019. Epub 2012 Feb 20.

PMID:
22351683
8.

Candidaemia in a Polish tertiary paediatric hospital, 2000 to 2010.

Dzierzanowska-Fangrat K, Romanowska E, Gryniewicz-Kwiatkowska O, Migdał M, Witulska K, Ryżko J, Kaliciński P, Książyk J, Nadkowska P, Dzierzanowska D.

Mycoses. 2014 Feb;57(2):105-9. doi: 10.1111/myc.12107. Epub 2013 Jul 8.

PMID:
23834472
9.

Species distribution and antifungal susceptibility of bloodstream fungal isolates in paediatric patients in Mexico: a nationwide surveillance study.

González GM, Treviño-Rangel Rde J, Palma-Nicolás JP, Martínez C, González JG, Ayala J, Caballero A, Morfín-Otero R, Rodríguez-Noriega E, Velarde F, Ascencio EP, Tinoco JC, Vázquez JA, Cano MA, León-Sicairos N, González R, Rincón J, Elías MA, Bonifaz A.

J Antimicrob Chemother. 2013 Dec;68(12):2847-51. doi: 10.1093/jac/dkt283. Epub 2013 Jul 18.

PMID:
23869052
10.

Epidemiology and antifungal susceptibility of bloodstream fungal isolates in pediatric patients: a Spanish multicenter prospective survey.

Pemán J, Cantón E, Linares-Sicilia MJ, Roselló EM, Borrell N, Ruiz-Pérez-de-Pipaon MT, Guinea J, García J, Porras A, García-Tapia AM, Pérez-Del-Molino L, Suárez A, Alcoba J, García-García I.

J Clin Microbiol. 2011 Dec;49(12):4158-63. doi: 10.1128/JCM.05474-11. Epub 2011 Oct 19.

11.

Epidemiology and echinocandin susceptibility of Candida parapsilosis sensu lato species isolated from bloodstream infections at a Spanish university hospital.

Garcia-Effron G, Canton E, Pemán J, Dilger A, Romá E, Perlin DS.

J Antimicrob Chemother. 2012 Nov;67(11):2739-48. doi: 10.1093/jac/dks271. Epub 2012 Aug 6.

12.

Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain.

Pemán J, Cantón E, Gobernado M; Spanish ECMM Working Group on Candidaemia.

Eur J Clin Microbiol Infect Dis. 2005 Jan;24(1):23-30.

PMID:
15619060
13.

Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme.

Arendrup MC, Dzajic E, Jensen RH, Johansen HK, Kjaeldgaard P, Knudsen JD, Kristensen L, Leitz C, Lemming LE, Nielsen L, Olesen B, Rosenvinge FS, Røder BL, Schønheyder HC.

Clin Microbiol Infect. 2013 Aug;19(8):E343-53. doi: 10.1111/1469-0691.12212. Epub 2013 Apr 22. Erratum in: Clin Microbiol Infect. 2013 Aug;19(8):E376.

14.

Species distribution and antifungal susceptibility of blood Candida isolates at a tertiary hospital in southern Taiwan, 1999-2006.

Chen PL, Lo HJ, Wu CJ, Lee HC, Chang CM, Lee NY, Wang AH, Lin WL, Ko NY, Lee CC, Ko WC.

Mycoses. 2011 Jul;54(4):e17-23. doi: 10.1111/j.1439-0507.2009.01818.x. Epub 2009 Dec 17.

PMID:
20028463
15.

Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain.

Bassetti M, Merelli M, Righi E, Diaz-Martin A, Rosello EM, Luzzati R, Parra A, Trecarichi EM, Sanguinetti M, Posteraro B, Garnacho-Montero J, Sartor A, Rello J, Tumbarello M.

J Clin Microbiol. 2013 Dec;51(12):4167-72. doi: 10.1128/JCM.01998-13. Epub 2013 Oct 9.

16.

Candidemia by species of the Candida parapsilosis complex in children's hospital: prevalence, biofilm production and antifungal susceptibility.

Ruiz LS, Khouri S, Hahn RC, da Silva EG, de Oliveira VK, Gandra RF, Paula CR.

Mycopathologia. 2013 Apr;175(3-4):231-9. doi: 10.1007/s11046-013-9616-5. Epub 2013 Feb 13.

PMID:
23404576
17.

Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2001-2010.

Chen CY, Huang SY, Tsay W, Yao M, Tang JL, Ko BS, Chou WC, Tien HF, Hsueh PR.

Int J Antimicrob Agents. 2012 Dec;40(6):533-8. doi: 10.1016/j.ijantimicag.2012.07.022. Epub 2012 Sep 21.

PMID:
23006521
18.

Candidaemia in Sweden: a nationwide prospective observational survey.

Ericsson J, Chryssanthou E, Klingspor L, Johansson AG, Ljungman P, Svensson E, Sjölin J.

Clin Microbiol Infect. 2013 Apr;19(4):E218-21. doi: 10.1111/1469-0691.12111. Epub 2013 Jan 17.

19.

[Changes in the epidemiology of fungaemia and fluconazole susceptibility of blood isolates during the last 10 years in Spain: results from the FUNGEMYCA study].

Pemán J, Cantón E, Miñana JJ, Florez JA, Echeverria J, Ortega DN, Alarcón JM, Fontanals D, Sard BG, Moreno BB, Torroba L, Ayats J, Pérez MÁ, Fernández MA, Reus FS, Natal IF, García GR, Ezpeleta G, Martín-Mazuelos E, Iglesias I, Rezusta A, de Ocariz IR, Nieto AG; el Grupo de Estudio FUNGEMYCA.

Rev Iberoam Micol. 2011 Apr-Jun;28(2):91-9. doi: 10.1016/j.riam.2011.02.005. Epub 2011 Mar 3. Spanish.

PMID:
21376831
20.

An investigation of Candida species isolated from blood cultures during 17 years in a university hospital.

Kazak E, Akın H, Ener B, Sığırlı D, Özkan Ö, Gürcüoğlu E, Yılmaz E, Çelebi S, Akçağlar S, Akalın H.

Mycoses. 2014 Oct;57(10):623-9. doi: 10.1111/myc.12209. Epub 2014 Jun 17.

PMID:
24934185

Supplemental Content

Support Center